Definity
Patient Information
PATIENT INFORMATION
Patients receiving activated DEFINITY® should be instructed to inform their healthcare provider if they:
- have a congenital heart defect, or recent worsening of heart or lung conditions,
- have had prior reactions to DEFINITY® (see CONTRAINDICATIONS and WARNINGS),
- may be pregnant, are trying to become pregnant, or are nursing.
Brand Name: Definity
Generic Name: Perflutren Lipid Microsphere
Generic Name: Perflutren Lipid Microsphere
« Previous: Definity - Clinical Pharmacology
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Heart Health
Get the latest treatment options.
WebMD Resources
At Risk for Heart Disease?
Thanks to new technology, in just 15 seconds you can tell if you’re at risk for heart disease. Learn about this new tool. See more WebMD Videos »

